Skip to main content

Are you Dr. Reed?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 29 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    211 N Eddy St
    South Bend, IN 46617
    Phone+1 574-246-8816
    Fax+1 574-204-6345

Summary

  • Dr. John Reed, MD is a board certified pediatrician in South Bend, Indiana. He is currently licensed to practice medicine in Indiana.

Education & Training

  • Saint Joseph Health System
    Saint Joseph Health SystemResidency, Family Medicine, 1991 - 1994
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Pediatrics, 1980 - 1983
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1980

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1980 - 2015
  • American Board of Pediatrics Pediatrics

Press Mentions

  • Sanofi : Positive Topline Results Demonstrated by Olipudase Alfa, First and Only Investigational Therapy in Late-Stage Development for Acid Sphingomyelinase Deficiency
    Sanofi : Positive Topline Results Demonstrated by Olipudase Alfa, First and Only Investigational Therapy in Late-Stage Development for Acid Sphingomyelinase DeficiencyJanuary 30th, 2020
  • Sanofi : Dupixent® (Dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal Polyposis
    Sanofi : Dupixent® (Dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal PolyposisOctober 29th, 2019
  • Sanofi : Dupixent® (Dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic Dermatitis
    Sanofi : Dupixent® (Dupilumab) Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years with Severe Atopic DermatitisAugust 6th, 2019
  • Join now to see all